Meribank Biotech Co., Ltd
Meribank Biotech Co., Ltd researches, develops, manufactures, and stores mesenchymal stem cells in Taiwan. The company engages in the detection, extraction, cryopreservation, archiving, and storage of umbilical cord blood, placental and umbilical cord mesenchymal stem cells, adult peripheral blood stem cells, and immune cells. It also provides cell cryopreservation services. The company was found… Read more
Market Cap & Net Worth: Meribank Biotech Co., Ltd (4724)
Meribank Biotech Co., Ltd (TWO:4724) has a market capitalization of $43.51 Million (NT$1.44 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #26051 globally and #1635 in its home market, demonstrating a 3.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Meribank Biotech Co., Ltd's stock price NT$15.00 by its total outstanding shares 95976406 (95.98 Million).
Meribank Biotech Co., Ltd Market Cap History: 2026 to 2026
Meribank Biotech Co., Ltd's market capitalization history from 2026 to 2026. Data shows growth from $43.51 Million to $43.51 Million (0.00% CAGR).
Meribank Biotech Co., Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Meribank Biotech Co., Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4724 by Market Capitalization
Companies near Meribank Biotech Co., Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Meribank Biotech Co., Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Meribank Biotech Co., Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, Meribank Biotech Co., Ltd's market cap moved from $43.51 Million to $ 43.51 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$43.51 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Meribank Biotech Co., Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.51 Million USD |
| MoneyControl | $43.51 Million USD |
| MarketWatch | $43.51 Million USD |
| marketcap.company | $43.51 Million USD |
| Reuters | $43.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.